The latest trends in trichology show a field that increasingly relies on a combination of precise diagnosis, clinical treatment, and hair restoration procedures. Hair transplantation remains among the primary surgical options for selected patients, while therapies such as platelet-rich plasma (PRP), microneedling, and photobiomodulation expand the possibilities for managing alopecia.
At the same time, new approaches linked to regenerative medicine are generating interest. Exosomes, stem cells, and other biological products are being researched, but they still vary significantly in terms of the level of evidence, standardization, and regulation. Therefore, keeping up with developments in the field also requires the ability to distinguish between an established therapy and an alternative that is still experimental.
In this article, you’ll learn how hair transplantation is evolving, which therapies are gaining traction, and which innovations still require more evidence before they can be widely incorporated into medical practice.
Trends in Trichology Go Beyond New Procedures
The evolution of trichology does not depend on a single technology. One of the most significant developments is precisely the integration of diagnostic testing, drug therapies, minimally invasive procedures, and—when indicated—hair transplantation.
This approach is especially relevant in conditions such as androgenetic alopecia. The patient may experience progressive hair loss even after hair restoration surgery, because the transplant redistributes existing follicles but does not necessarily affect the progression of the non-transplanted hairs. For this reason, surgical planning and clinical treatment can be part of the same strategy.
Advances in the field are also linked to the individualization of treatment approaches. Age, pattern of alopecia, quality of the donor area, associated medical conditions, and the patient’s expectations all influence the therapeutic decision.
Hair transplantation enters a phase of greater precision
Hair transplantation uses follicular units harvested from a donor region to fill in areas with permanent hair loss. The technique does not create new follicles. The goal is to redistribute existing follicles in a planned manner, seeking to preserve the donor area and achieve a result consistent with each patient’s characteristics.
A review published in 2025 on the current state of hair surgery highlights advances related to patient selection, instrumentation, planning, graft extraction, and post-procedure care. The most recent literature thus reinforces that the evolution of hair transplantation lies not only in the creation of new techniques but primarily in the refinement of all stages of the surgery.
In this process, aspects such as hairline design, graft distribution, and prediction of the future progression of alopecia take on greater importance. A transplant performed without considering the progression of the condition may produce unsatisfactory results over time, even if the initial surgery achieves good graft integration.
Would you like to deepen your knowledge of diagnosis, treatments, and procedures related to hair health? Learn about the Postgraduate Program in Trichology at São Leopoldo Mandic. CLICK HERE to learn more.
What trends in trichology are transforming the FUE technique?
Follicular Unit Excision (FUE) remains one of the primary methods used in hair transplantation. In this technique, follicular units are individually extracted from the donor area using small instruments and then transferred to the recipient area.
FUE avoids the removal of a linear strip of scalp, which is characteristic of the FUT technique. However, this does not mean there are no risks. The literature describes possible complications related to the donor area, scarring, folliculitis, changes in sensitivity, and other events that must be considered during patient planning and follow-up.
Current advances are primarily related to the development of more precise instruments and efforts to reduce transection or damage to follicular units during extraction. At the same time, planning of the donor area is receiving greater attention to prevent excessive follicle removal and subsequent aesthetic impairment.
Technology and automation are also making their way into hair transplantation
Digital equipment and surgical support systems are playing an increasingly important role in hair restoration procedures. Among the possibilities are tools capable of assisting in the identification and selection of follicular units, as well as resources aimed at standardizing certain stages of extraction.
The use of these technologies is part of a broader trend toward increased surgical precision. However, they function as supportive tools. Clinical evaluation, hairline design, and the determination of graft distribution continue to depend on individualized medical decisions.
Technology, therefore, does not eliminate the need for technical expertise. On the contrary, advances in equipment increase the need for professionals capable of understanding its indications, limitations, and impact on the outcome of the procedure.
Trends in Trichology Reinforce the Integration of Surgery and Clinical Treatment
Hair transplantation should not be analyzed in isolation. In many patients with androgenetic alopecia, for example, the hairs that were not transplanted remain subject to the progression of the condition.
Therefore, clinical strategies may be recommended before or after surgery, depending on the diagnosis and the individual’s profile. The goal may be to stabilize hair loss, preserve existing hair, or complement the results achieved through the procedure.
This integrated approach changes the logic of treatment. Instead of choosing between surgery or clinical follow-up, the physician can incorporate different resources into the stages of a single treatment plan, when indicated.
PRP Remains Among the Most Studied Therapies
Platelet-rich plasma, or PRP, remains one of the most extensively studied adjunctive therapies in trichology. The technique uses an autologous preparation derived from the patient’s own blood, containing a higher concentration of platelets and factors related to tissue repair mechanisms.
A meta-analysis published in 2024 identified an increase in hair density in patients with androgenetic alopecia who underwent PRP treatment, although the results for other parameters were less consistent. The authors also highlight important differences between the protocols used in the studies.
Research is also evaluating PRP in combination with treatments already used for androgenetic alopecia. A meta-analysis on the combination of PRP and minoxidil found improvements in some outcomes, but another review notes that the quality of the evidence may still be low due to the small number of studies and the heterogeneity of PRP preparation methods.
Therefore, despite growing interest, there is still no single universal PRP protocol for all patients.
Microneedling Expands the Possibilities in Trichology
Microneedling has gained traction primarily as an adjunct therapy for the treatment of androgenetic alopecia. The procedure involves controlled microperforations of the scalp and has been studied in various protocols and therapeutic combinations.
A systematic review with a meta-analysis published in 2025 compared microneedling combined with minoxidil to the use of the medication alone. The studies analyzed showed superior results for the combination therapy in parameters such as hair count and diameter.
However, there is still variation in the protocols. Needle depth, the device used, the number of sessions, and the interval between treatments differ across published studies. This makes it difficult to establish a single strategy applicable to all patients.
Interest in microneedling also reflects a broader trend in the field: using different therapeutic mechanisms in a complementary manner, provided there is an appropriate clinical indication.
Photobiomodulation Gains Ground as a Complementary Therapy
Photobiomodulation uses low-intensity light sources to stimulate cellular mechanisms related to the hair follicle. This approach may also be referred to in the literature as low-level light therapy (LLLT).
This technique has been studied primarily in the context of androgenetic alopecia and may be considered a complementary therapy in specific settings. However, as with other procedures, its use must be based on a correct diagnosis.
Hair loss may be related to various dermatological, hormonal, nutritional, autoimmune, or inflammatory conditions. Therefore, a technology designed to stimulate the hair follicle does not replace an investigation into the cause of alopecia.
Would you like to deepen your knowledge of diagnosis, treatments, and procedures related to hair health? Learn about the Postgraduate Program in Trichology at São Leopoldo Mandic. CLICK HERE to learn more.
Exosomes represent one of the most discussed trends in trichology
Exosomes have sparked great interest in the field of regenerative medicine. These extracellular vesicles play a role in intercellular communication and carry components such as proteins, lipids, and genetic material, which has led researchers to investigate potential applications in follicle regeneration.
A systematic review published in 2025 identified clinical studies evaluating exosome-based therapies for different forms of hair loss. Initial results show potential, but the authors themselves point out limitations related to the small number of patients, the diversity of product sources, and the lack of standardized protocols.
For this reason, exosomes should not be treated as an established therapy for alopecia. Research still needs to advance in areas such as comparative efficacy, long-term safety, and standardization.
Regulatory issues also require attention. The FDA has issued warnings regarding unapproved products marketed as regenerative therapies, including products containing exosomes. In 2026, the agency once again warned consumers about risks associated with unapproved human cell or tissue products.
Cell therapies are still in the research phase
Stem cells and other regenerative strategies are also being studied as potential avenues for treating different forms of hair loss. The goal of several lines of research is to understand whether cell-derived products could stimulate processes associated with follicle activity.
However, biological potential does not equate to proven clinical benefit. Questions remain regarding safety, product standardization, methods of administration, and long-term outcomes.
In Brazil, Anvisa warns of the risks of using unapproved stem cell-based products and advises caution regarding therapeutic claims without regulatory backing.
This distinction is particularly relevant in a field where new therapies may gain visibility before sufficient studies exist to prove their benefits.
How do trends in trichology favor combination therapies?
The combination of different therapeutic modalities is appearing with increasing frequency in research on androgenetic alopecia. Studies evaluate, for example, minoxidil combined with microneedling, PRP combined with minoxidil, and various combinations of clinical therapies and procedures.
Initial results help us understand how complementary mechanisms can contribute to treatment. However, there is no one-size-fits-all standard combination suitable for all patients. The selection depends on the etiology of the alopecia, the stage of hair loss, contraindications, and the individual’s response.
The most significant advance, therefore, does not simply lie in using more treatments at the same time. It lies in the ability to select and combine treatments rationally, based on evidence and an individualized assessment.
Diagnosis becomes even more important given the multitude of options
The greater the number of available technologies, the greater the need for a well-established diagnosis. Hair loss does not represent a single disease, and different types of alopecia may require completely different approaches.
The evaluation may involve medical history, scalp examination, trichoscopy, and additional tests, depending on the suspected diagnosis. In some cases, further investigations may be necessary to differentiate between scarring conditions, inflammatory conditions, or changes related to systemic factors.
This approach prevents treatment from being chosen solely based on the availability of a particular technology. The most consistent trend in trichology remains personalized treatment based on diagnosis.
Trends in Trichology Require Constant Scientific Updates
The speed at which new procedures enter clinical practice makes staying up to date an essential part of working in trichology. Professionals must understand not only how a technology works but also the quality of the evidence supporting its use.
This involves interpreting clinical studies, recognizing methodological limitations, and keeping abreast of regulatory changes. Technologies that appear promising in initial research may not yield the same results when evaluated in larger studies.
At the same time, established treatments are also undergoing revisions and being combined in new ways. Staying current, therefore, is not limited to new developments. It also involves keeping abreast of evolving evidence regarding therapies that are already part of clinical practice.
Graduate Program in Trichology at São Leopoldo Mandic
For physicians who wish to deepen their knowledge in this field, São Leopoldo Mandic College offers a Postgraduate Program in Trichology, designed to develop theoretical and practical skills related to caring for patients with various hair-related concerns.
The institution also offers training in Clinical Trichology in a hybrid format, combining theoretical activities with in-person sessions focused on practical application. Information on the course structure and format is available on the program’s official website.
Given the growing number of procedures and therapies, a structured training program can help develop a comprehensive approach that integrates diagnosis, scientific interpretation, and clinical decision-making.
Would you like to deepen your knowledge of diagnosis, treatments, and procedures related to hair health? Learn about the Postgraduate Program in Trichology at São Leopoldo Mandic. CLICK HERE to learn more.
What can we expect from the future of Trichology?
Trends in Trichology point toward a future based less on a single revolutionary technology and more on the refinement of existing strategies. Physicians are increasingly integrating hair transplants, pharmacological treatments, and complementary procedures into increasingly personalized treatment plans.
At the same time, research into exosomes and cell therapies is expanding the possibilities for investigation. However, these approaches still need to overcome significant gaps before they can be considered established treatments.
For physicians, keeping pace with this process means balancing innovation with evidence. Learning about a new technology is only part of the journey; understanding when it is indicated, what results can be expected, and what limitations still exist is what allows for its responsible incorporation into practice.
Final Thoughts
Trends in trichology show that hair care is moving toward increasingly integrated approaches. Hair transplantation is undergoing technical refinements, while PRP, microneedling, and other complementary therapies continue to be evaluated in different clinical contexts.
At the same time, exosomes and cell therapies demonstrate how innovation can open new avenues of research without necessarily representing a ready-made solution for clinical practice. For physicians, keeping pace with these developments requires the ability to interpret evidence, recognize limitations, and select treatment strategies based on each patient’s diagnosis.
FAQ on Trends and Treatments in Trichology
Is hair transplantation still a trend in trichology?
Yes. Hair transplantation remains relevant, but its evolution is primarily related to refinements in planning, the extraction of follicular units, and the preservation of the donor area.
Is FUE currently the only hair transplant technique?
No. FUE and linear follicular unit extraction methods are still described in the literature. The choice depends on the patient’s characteristics, the donor area, and the surgical plan.
Can PRP be used to treat androgenetic alopecia?
PRP has been studied for androgenetic alopecia, and meta-analyses have identified improved hair density in some groups. However, there is still variation among protocols and in the quality of the evidence.
Does microneedling work better when combined with minoxidil?
A meta-analysis published in 2025 found better results for microneedling combined with minoxidil compared to the use of minoxidil alone in patients with androgenetic alopecia. The protocols used, however, varied.
Are exosomes already an established therapy for hair loss?
No. Initial studies show promising results, but there are still limitations related to patient numbers, standardization, and safety data.
How can one learn more about the latest trends in trichology?
Physicians interested in the field can seek specialized training to deepen their knowledge of diagnosis, clinical therapies, and procedures. São Leopoldo Mandic College offers a postgraduate program in Trichology designed for physicians.
If you want to take the next step in your professional career, the postgraduate program in Trichology at São Leopoldo Mandic is the right choice. CLICK HERE to learn more.
References
NATIONAL HEALTH SURVEILLANCE AGENCY (ANVISA). ANVISA warns of risks associated with the use of unapproved stem cell-based products. Brasília, Sept. 24, 2024.
AHMED, K. M. A. et al. Evaluating the efficacy and safety of combined microneedling therapy versus topical minoxidil in androgenetic alopecia: a systematic review and meta-analysis. 2025.
AL AMEER, M. A. et al. Exosomes and hair regeneration: a systematic review of clinical evidence. 2025.
LI, M. et al. Effectiveness of platelet-rich plasma in the treatment of androgenic alopecia: a meta-analysis. Aesthetic Plastic Surgery, vol. 48, no. 5, pp. 977–984, 2024.
PODDAR, N. et al. Therapeutic potential of stem cell-derived exosomes in hair regeneration. 2025.
QUEEN, D. et al. Hair transplantation: state of the art. 2025.
UNITED STATES FOOD AND DRUG ADMINISTRATION (FDA). Consumer alert on regenerative medicine products, including stem cells and exosomes.
UNITED STATES FOOD AND DRUG ADMINISTRATION (FDA). Patient and consumer warning about potential serious risks following the use of unapproved products. 2026.
